It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Heart failure (HF) is associated with a high prevalence of unwanted loneliness. This study aimed to assess whether unwanted loneliness was associated with adverse clinical endpoints in HF patients. Additionally, we also aimed to examine the risk factors associated with unwanted loneliness in HF. We included 298 patients diagnosed with stable HF. Clinical, biochemical, echocardiographic parameters and loneliness using ESTE II scale were assessed. We analyzed the association between the exposure and adverse clinical endpoints by Cox (death or any hospitalization), and negative binomial regressions (recurrent hospitalizations or visits to the emergency room). Risk factors associated with loneliness were analyzed using logistic regression. The mean age was 75.8 ± 9.4 years, with 111 (37.2%) being women, 53 (17.8%) widowed, and 154 (51.7%) patients having preserved ejection fraction. The median (p25–p75%) ESTE II score was 9.0 (6.0–12.0), and 36.9% fulfilled the loneliness criteria (> 10). Both women (OR = 2.09; 95% CI 1.11–3.98, p = 0.023) and widowhood (OR = 3.25; 95% CI 1.51–7.01, p = 0.003) were associated with a higher risk of loneliness. During a median follow-up of follow-up of 362 days (323–384), 93 patients (31.3%) presented the combined episode of death or all-cause admissions. Loneliness was significantly related to the risk of time to the composite of death or any readmission during the composite (HR = 1.83; 95% CI 1.18–2.84, p = 0.007). Women and widowhood emerge as risk factors for unwanted loneliness in HF patients. Unwanted loneliness is associated with higher morbidity during follow-up.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Hospital Clínico Universitario de Valencia, University of Valencia, INCLIVA, Department of Cardiology, Valencia, Spain
2 Hospital Clínico Universitario de Valencia, University of Valencia, INCLIVA, Department of Cardiology, Valencia, Spain; CIBER Cardiovascular, Madrid, Spain (GRID:grid.512890.7)
3 Hospital Clínico Universitario de Valencia, University of Valencia, INCLIVA, Department of Cardiology, Valencia, Spain (GRID:grid.512890.7)
4 Hospital Clínico Universitario de Valencia, University of Valencia, INCLIVA, Department of Cardiology, Valencia, Spain (GRID:grid.512890.7); CIBER Cardiovascular, Madrid, Spain (GRID:grid.512890.7); University of Valencia, Departament of Medicine, Valencia, Spain (GRID:grid.5338.d) (ISNI:0000 0001 2173 938X)